成人1型糖尿病中艾迪生病的早期临床指标:全国性观察性队列研究
该研究基于瑞典国家登记数据,纳入1998至2013年间36,514例成人1型糖尿病患者,其中66例合并艾迪生病,按1:5匹配330例对照。分析发现,基线前甲状腺/抗甲状腺药物处方频率在病例组更高(9.1% vs 1.8%);诊断艾迪生病前,病例组视网膜病变(12.1% vs 2.1%)、需住院感染(16.7% vs 2.1%)、甲状腺/抗甲状腺药物处方(28.8% vs 7.0%)及胰高血糖素处方(18.2% vs 6.4%)频率均更高,而糖化血红蛋白无差异。
要点
- 甲状腺药物处方、严重感染住院和胰高血糖素处方可能提示成人1型糖尿病患者发生艾迪生病。
- 糖尿病视网膜病变出现可能与糖皮质激素缺乏及艾迪生病发展相关。
- 糖化血红蛋白在基线前或艾迪生病诊断前组间无差异。
核心结论
- 甲状腺疾病药物治疗、严重感染和因严重低血糖开具胰高血糖素处方应提高对成人1型糖尿病患者发生艾迪生病的怀疑。
- 糖尿病视网膜病变的发展也可能与糖皮质激素缺乏及艾迪生病发生相关。
研究设计与样本
- 观察性匹配队列研究,数据来自瑞典国家登记(国家糖尿病登记、住院登记和处方药物登记)。
- 纳入1998至2013年国家糖尿病登记中36,514例成人1型糖尿病患者,其中66例合并艾迪生病,每例匹配5例单纯1型糖尿病对照(共330例)。
主要发现
- 基线前,病例组甲状腺/抗甲状腺药物处方频率高于对照组(9.1% vs 1.8%)。
- 艾迪生病诊断前,病例组糖尿病视网膜病变频率高于对照组(12.1% vs 2.1%)。
- 艾迪生病诊断前,病例组需住院感染的频率高于对照组(16.7% vs 2.1%)。
- 艾迪生病诊断前,病例组甲状腺/抗甲状腺药物处方频率高于对照组(28.8% vs 7.0%)。
- 艾迪生病诊断前,病例组胰高血糖素处方频率高于对照组(18.2% vs 6.4%)。
关键数值与推荐
- 基线前甲状腺/抗甲状腺药物处方频率:病例组9.1%,对照组1.8%。
- 艾迪生病诊断前糖尿病视网膜病变频率:病例组12.1%,对照组2.1%。
- 艾迪生病诊断前需住院感染频率:病例组16.7%,对照组2.1%。
- 艾迪生病诊断前甲状腺/抗甲状腺药物处方频率:病例组28.8%,对照组7.0%。
- 艾迪生病诊断前胰高血糖素处方频率:病例组18.2%,对照组6.4%。
临床怎么用
- 对成人1型糖尿病患者,出现甲状腺疾病药物治疗、严重感染住院或因严重低血糖开具胰高血糖素时,应考虑筛查艾迪生病。
- 糖尿病视网膜病变的出现也可能提示糖皮质激素缺乏,需警惕艾迪生病可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Patients with type 1 diabetes mellitus (T1DM) have an increased risk of Addison disease (AD) development, but prediction of those at risk is not possible. OBJECTIVE: To determine whether there are early clinical indicators that may denote the development of AD in adults with T1DM. DESIGN: Observational, matched-cohort study. SETTING: Patient data from Swedish national registries [National Diabetes Register (NDR), Inpatient Register, and Prescription Drug Register]. PARTICIPANTS: All patients with T1DM diagnosed with concomitant AD (n = 66) among the 36,514 adult patients with T1DM in the NDR between 1998 and 2013. Each case was matched to five controls with T1DM alone (n = 330). MAIN OUTCOME MEASURES: Clinical data and drug prescriptions were assessed prior to baseline (inclusion into the study) and prior to AD diagnosis. Analysis of covariance and estimated group proportions were used for comparisons. RESULTS: Prior to baseline, cases had a higher frequency of thyroid/antithyroid drug prescription than controls (9.1% vs 1.8%). Prior to AD diagnosis, cases had higher frequencies of diabetic retinopathy (12.1% vs 2.1%), infections requiring hospital admission (16.7% vs 2.1%), thyroid/antithyroid drug prescription (28.8% vs 7.0%), and glucagon prescription (18.2% vs 6.4%). There was no difference in glycated Hb between the groups prior to baseline or prior to AD diagnosis. CONCLUSIONS: These data suggest that medical treatment of thyroid disease, a severe infection, and glucagon prescription for severe hypoglycemia should raise the suspicion of AD development in adults with T1DM. Development of diabetic retinopathy might also be associated with glucocorticoid deficiency and the development of AD among patients with T1DM.
引用
- Chantzichristos D, Persson A, Miftaraj M, et al. Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study. J Clin Endocrinol Metab. 2019. PMID: 30476180. doi:10.1210/jc.2018-02064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。